NCT04341012View on ClinicalTrials.gov

Breath Analysis Based Disease Biomarkers

CompletedOBSERVATIONAL

Enrollment

46

Participants

Timeline

Start Date

September 10, 2019

Primary Completion Date

September 3, 2021

Study Completion Date

September 3, 2021

Conditions

Liver DiseasesLiver CancerCOVID19

Interventions

DIAGNOSTIC_TEST

Collection of breath sample

Analysis of volatile organic compounds in breath

Trial Locations (1)

32224

Mayo Clinic Florida, Jacksonville

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER

NCT04341012 - Breath Analysis Based Disease Biomarkers | Biotech Hunter | Biotech Hunter